Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,225
datasets available to search
ShareScore release 0.9.0
Dataset results
5,225 results for “moderation”
Efficacy&Safety of ALTB-168 in Patients With Moderate to Severe Active,Anti-TNF Alpha and/or Anti-integrin Refractory UC
ClinicalTrials.gov study NCT03298022. IPD Sharing: NO. Countries: 2. Publications: 0.
Efficacy and Safety of the Combination of Aliskiren (300 mg) and Amlodipine (10 mg) Compared to Amlodipine (10 mg) Monotherapy in Patients With Moderate to Severe Hypertension
ClinicalTrials.gov study NCT00841672. IPD Sharing: Not stated. Countries: 6. Publications: 0.
A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis
ClinicalTrials.gov study NCT05999799. IPD Sharing: YES. Countries: 17. Publications: 0.
A Study to Evaluate the Effect of Mild and Moderate Hepatic Impairment on the Single-Dose Pharmacokinetics of Rilzabrutinib (PRN1008)
ClinicalTrials.gov study NCT06444204. IPD Sharing: YES. Countries: 1. Publications: 0.
Study to Assess the Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours and Normal Liver Function or Mild or Moderate Liver Impairment
ClinicalTrials.gov study NCT01894243. IPD Sharing: Not stated. Countries: 5. Publications: 0.
A Study of LY3454738 in the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis
ClinicalTrials.gov study NCT05911841. IPD Sharing: YES. Countries: 9. Publications: 0.
A 12-week Randomized Study to Evaluate Oral Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
ClinicalTrials.gov study NCT01968031. IPD Sharing: Not stated. Countries: 8. Publications: 0.
Treatment of Moderate to Severe Lateral Canthal Lines
ClinicalTrials.gov study NCT04249687. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Long-Term Extension Study of WA22763 and NA25220 of Subcutaneous RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis
ClinicalTrials.gov study NCT01772316. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Analysis of Adherence in Subjects Undergoing Differin Gel, 0.1% Treatment of Moderate to Severe Acne Vulgaris
ClinicalTrials.gov study NCT00696449. IPD Sharing: NO. Countries: 1. Publications: 0.
Comparison of Dysport Reconstitution at 1.5 mL and 2.5 mL for the Treatment of Moderate to Severe Glabellar Lines
ClinicalTrials.gov study NCT02718118. IPD Sharing: NO. Countries: 1. Publications: 0.
Split-face Study Comparing the Cosmetic Efficacy and Tolerability of Two Topical Products in Participants With Moderate Facial Melasma
ClinicalTrials.gov study NCT02977507. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effects of Usage of Simvastatin in Mild to Moderate Traumatic Brain Injury (TBI) Patients. Could it Make a Difference?
ClinicalTrials.gov study NCT05551871. IPD Sharing: UNDECIDED. Countries: 0. Publications: 6.
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT01622348. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fentanyl Sublingual Spray for the Treatment of Moderate to Severe Post-Operative Pain
ClinicalTrials.gov study NCT02915978. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Crossover Study to Assess the Efficacy of PT003 With and Without a Valved Holding Chamber in Subjects With Moderate to Severe COPD
ClinicalTrials.gov study NCT02454959. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Deucravacitinib Versus Placebo in Participants With Moderate-to-severe Scalp Psoriasis
ClinicalTrials.gov study NCT05478499. IPD Sharing: Not stated. Countries: 5. Publications: 0.
An Open-Label, Prospective Study to Assess the Safety and Effectiveness of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in the Russian Federation
ClinicalTrials.gov study NCT01644396. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluate the Efficacy and Safety of Fasinumab in Patients With Moderate-to-Severe Chronic Low Back Pain and Osteoarthritis of the Hip or Knee
ClinicalTrials.gov study NCT03285646. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis
ClinicalTrials.gov study NCT01670045. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.